Literature DB >> 28164849

Fecal Microbiota Transplantation.

Stephen M Vindigni1, Christina M Surawicz2.   

Abstract

Fecal microbiota transplantation (FMT) is the transfer of stool from a healthy donor into the colon of a patient whose disease is a result of an altered microbiome, with the goal of restoring the normal microbiota and thus curing the disease. The most effective and well-studied indication for FMT is recurrent Clostridium difficile infection. At this time, there is insufficient evidence to recommend FMT for other gastrointestinal diseases, but studies are under way. There is also insufficient evidence to recommend FMT for nongastrointestinal diseases at this time. The field is rapidly emerging.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Clostridium difficile; FMT; Fecal microbiota transplant; Microbiome; Stool transplant

Mesh:

Year:  2017        PMID: 28164849     DOI: 10.1016/j.gtc.2016.09.012

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  59 in total

Review 1.  The crucial role of early-life gut microbiota in the development of type 1 diabetes.

Authors:  He Zhou; Lin Sun; Siwen Zhang; Xue Zhao; Xiaokun Gang; Guixia Wang
Journal:  Acta Diabetol       Date:  2020-07-25       Impact factor: 4.280

Review 2.  Harnessing Gut Microbes for Mental Health: Getting From Here to There.

Authors:  Annadora J Bruce-Keller; J Michael Salbaum; Hans-Rudolf Berthoud
Journal:  Biol Psychiatry       Date:  2017-08-30       Impact factor: 13.382

Review 3.  Targeting friend and foe: Emerging therapeutics in the age of gut microbiome and disease.

Authors:  Jin Ah Cho; Daniel J F Chinnapen
Journal:  J Microbiol       Date:  2018-02-28       Impact factor: 3.422

Review 4.  Enhancing the accuracy of next-generation sequencing for detecting rare and subclonal mutations.

Authors:  Jesse J Salk; Michael W Schmitt; Lawrence A Loeb
Journal:  Nat Rev Genet       Date:  2018-03-26       Impact factor: 53.242

Review 5.  The Gut Microbiome as a Therapeutic Target for Cognitive Impairment.

Authors:  Yi Sun; Liliana C Baptista; Lisa M Roberts; Patricia Jumbo-Lucioni; Lori L McMahon; Thomas W Buford; Christy S Carter
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2020-06-18       Impact factor: 6.053

Review 6.  Finding intestinal fortitude: Integrating the microbiome into a holistic view of depression mechanisms, treatment, and resilience.

Authors:  M C Flux; Christopher A Lowry
Journal:  Neurobiol Dis       Date:  2019-08-24       Impact factor: 5.996

Review 7.  Inflammatory Mediators in Mood Disorders: Therapeutic Opportunities.

Authors:  Madeline L Pfau; Caroline Ménard; Scott J Russo
Journal:  Annu Rev Pharmacol Toxicol       Date:  2017-10-06       Impact factor: 13.820

Review 8.  Modulation of gut microbiome in nonalcoholic fatty liver disease: pro-, pre-, syn-, and antibiotics.

Authors:  Min Seok Cho; Sang Yeol Kim; Ki Tae Suk; Byung-Yong Kim
Journal:  J Microbiol       Date:  2018-10-25       Impact factor: 3.422

Review 9.  [Development and prospects of fecal microbiota transplantation].

Authors:  Yue Hu; Bin Lyu
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2019-05-25

Review 10.  The role of the gut microbiome in opioid use.

Authors:  Michelle Ren; Shahrdad Lotfipour
Journal:  Behav Pharmacol       Date:  2020-04       Impact factor: 2.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.